BD to Host Virtual 2025 Annual Meeting of Shareholders
Becton, Dickinson and Company, widely known as BD, is gearing up to conduct its Annual Meeting of Shareholders in a completely virtual format on January 28, 2025. This meeting presents a unique opportunity for shareholders to engage directly with the company's leadership from the comfort of their own homes.
Meeting Details
The virtual meeting will commence at 1:00 PM ET. Shareholders who held shares prior to the cut-off date of December 9, 2024, will be eligible to attend and participate fully. They can exercise their voting rights and pose questions through the online portal at
meetnow.global/M5X7D4A. Remarkably, interested guests will also be able to access the meeting, albeit in a listen-only capacity without the ability to vote.
BD is committed to ensuring that shareholders can participate effectively. To facilitate this, a replay of the meeting will be made available on its investor relations webpage within a short period following the event. The replay is expected to remain accessible for approximately one year.
About Becton, Dickinson and Company
As one of the largest medical technology companies globally, BD has been at the forefront of advancing health through innovative medical solutions and diagnostics. Their mission transcends beyond standard healthcare; they are dedicated to improving patient outcomes and enhancing the efficiency of health care delivery. With a workforce exceeding 70,000, BD's commitment to developing state-of-the-art technologies and services empowers healthcare providers and researchers alike.
The company actively collaborates with health care professionals to better understand their needs, allowing them to create solutions that not only advance clinical practices but also address complexities within the healthcare sector. With a global presence, BD is well-equipped to deal with some of the most pressing health challenges worldwide.
BD is known for its technological advances in diagnostics, and its partnerships resonate deeply within the health community as they strive to lower costs while improving the effectiveness of health care delivery. As the medical landscape continues to evolve, BD's dedicated approach helps to enhance safety, increase efficiency, and provide enhanced access to health care services for communities everywhere.
In summary, BD's virtual meeting is not just an annual formality; it's a significant opportunity for shareholders and stakeholders to participate actively in the future direction of a company that plays an essential role in global health. BD's commitment to innovation in diagnostics, healthcare delivery and patient safety sets a robust foundation for meaningful dialogue during their upcoming Annual Meeting.
Moving forward, shareholders can look forward to hearing critical updates and insights from BD’s leadership, underlining the positive trajectories that the company aims to achieve as they contribute to advancing the world of health.